We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

By MedImaging International staff writers
Posted on 12 Nov 2024
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms of coronary artery disease (CAD). The late-breaking results from the CONFIRM2 global multicenter study highlighted the key atherosclerotic features most strongly linked to major adverse cardiovascular events (MACE) and revealed that these features are more reliable than traditional clinical risk scores.

In this study, which involved 3,551 symptomatic patients from 18 sites across 13 countries, researchers at Leiden University Medical Center (Leiden, Netherlands) used cutting-edge AI technology to analyze coronary computed tomography angiography (CCTA) data. The analysis revealed that two specific factors were the strongest indicators of MACE: 1) % Diameter Stenosis and 2) Non-Calcified Plaque Volume. Additionally, the CONFIRM2 study demonstrated that coronary artery calcified plaque volume did not independently predict negative outcomes for patients. These findings suggest that AI-driven evaluations could play a significant role in shaping treatment decisions, improving patient outcomes, and reducing the incidence of cardiovascular events in individuals with CAD.

"The integration of AI in assessing coronary artery disease represents a transformative leap in our ability to predict and manage coronary heart disease-related events,” said Dr. James K. Min, Founder and CEO of Cleerly. “AI-QCT analysis of cardiac CT provides diameter stenosis percentages and an accurate view of non-calcified plaque volume based on millions of images. This research not only highlights the potential of AI to improve diagnostic accuracy but also the importance of early intervention in reducing the risk of serious cardiovascular events."

Digital X-Ray Detector Panel
Acuity G4
Pocket Fetal Doppler
CONTEC10C/CL
Multi-Use Ultrasound Table
Clinton
Ultrasound Table
Women’s Ultrasound EA Table

Channels

Imaging IT

view channel
Image: QT Imaging’s latest breast imaging software adds enhanced reflection images by combining speed-of-sound and reflection data (photo courtesy of QT Imaging)

Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases

Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.